Weekly Policy Update: CBSA Applauds Introduction of House Bill to Permanently Repeal Medical Device Excise Tax

This week bipartisan legislation was introduced in the U.S. House of Representatives to permanently repeal the medical device excise tax. CBSA applauds the introduction of H.R. 2207, Protect Medical Innovation Act of 2019, which gets us one step closer to providing innovators the long-term certainty they need to support future job growth and sustainable, cutting-edge research and development.

As we work to ensure that full repeal of the medical device tax is addressed this year, it is critical that we tell policymakers just how damaging it would be to patient care and job creation if they allowed the device tax to be reinstated in 2020.

Please take this short survey created by our partners at the Medical Device Manufacturers Association (MDMA) on how reinstatement of the medical device tax would impact a company’s ability to grow and innovate.

Our champions in Congress have told us how important it is that we provide data on the impact of the device tax, so please take a few minutes to complete this survey.

The responses are anonymous and will be aggregated.

Categories: CBSA News